Skip to main content
Fig. 1 | Respiratory Research

Fig. 1

From: A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease

Fig. 1

Patient categories based on exacerbation history, airflow limitation and the risks of inhaled corticosteroid withdrawal. ACO, asthma-chronic obstructive pulmonary disease overlap; B, benefits of ICS withdrawal; FEV1, forced expiratory volume in 1 s; ICS, inhaled corticosteroid; R, risks associated with ICS withdrawal; dark green = ICS should be discontinued; red = ICS should not be withdrawn; pale green, pale red, or yellow = ICS withdrawal should be carefully evaluated on a case-by-case basis, taking into account the risk of ICS-associated adverse effects

Back to article page

Respiratory Research

ISSN: 1465-993X

Contact us